Insights

Loading spinner
Gathering insights about ImmunoGen, Inc.

Similar companies to ImmunoGen, Inc.

ImmunoGen, Inc. Tech Stack

ImmunoGen, Inc. uses 8 technology products and services including SiteCatalyst, WordPress, Google Charts, and more. Explore ImmunoGen, Inc.'s tech stack below.

  • SiteCatalyst
    Analytics
  • WordPress
    Content Management System
  • Google Charts
    Javascript Graphics
  • Underscore.js
    Javascript Libraries
  • SWFObject
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • Yoast SEO
    Search Engines
  • Adobe Creative Suite
    Visualisation Software

Media & News

ImmunoGen, Inc.'s Email Address Formats

ImmunoGen, Inc. uses at least 1 format(s):
ImmunoGen, Inc. Email FormatsExamplePercentage
First.Last@immunogen.comJohn.Doe@immunogen.com
73%
FLast@immunogen.comJDoe@immunogen.com
21%
Last@immunogen.comDoe@immunogen.com
4%
Last.First@immunogen.comDoe.John@immunogen.com
2%

Frequently Asked Questions

What is ImmunoGen, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact ImmunoGen, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ImmunoGen, Inc.'s stock symbol?

Minus sign iconPlus sign icon
ImmunoGen, Inc. is a publicly traded company; the company's stock symbol is IMGN.

What is ImmunoGen, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
ImmunoGen, Inc.'s official website is immunogen.com and has social profiles on LinkedInCrunchbase.

How much revenue does ImmunoGen, Inc. generate?

Minus sign iconPlus sign icon
As of December 2025, ImmunoGen, Inc.'s annual revenue is estimated to be $86M.

What is ImmunoGen, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
ImmunoGen, Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ImmunoGen, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, ImmunoGen, Inc. has approximately 10K employees across 5 continents, including North AmericaEuropeAsia. Key team members include Ceo: M. S.Ceo: S. S.Cso: J. L.. Explore ImmunoGen, Inc.'s employee directory with LeadIQ.

What industry does ImmunoGen, Inc. belong to?

Minus sign iconPlus sign icon
ImmunoGen, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does ImmunoGen, Inc. use?

Minus sign iconPlus sign icon
ImmunoGen, Inc.'s tech stack includes SiteCatalystWordPressGoogle ChartsUnderscore.jsSWFObjectMicrosoft AzureYoast SEOAdobe Creative Suite.

What is ImmunoGen, Inc.'s email format?

Minus sign iconPlus sign icon
ImmunoGen, Inc.'s email format typically follows the pattern of First.Last@immunogen.com. Find more ImmunoGen, Inc. email formats with LeadIQ.

How much funding has ImmunoGen, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, ImmunoGen, Inc. has raised $62M in funding. The last funding round occurred on May 09, 2023 for $62M.

ImmunoGen, Inc.

Pharmaceutical ManufacturingIllinois, United States10001+ Employees

ImmunoGen is now part of AbbVie.  

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.   

For more information about AbbVie, please visit us at www.abbvie.com. Follow AbbVie on LinkedIn for future updates.  

Review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Section iconCompany Overview

Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
IMGN
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
10001+

Section iconFunding & Financials

  • $62M

    ImmunoGen, Inc. has raised a total of $62M of funding over 7 rounds. Their latest funding round was raised on May 09, 2023 in the amount of $62M.

  • $50M$100M

    ImmunoGen, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $62M

    ImmunoGen, Inc. has raised a total of $62M of funding over 7 rounds. Their latest funding round was raised on May 09, 2023 in the amount of $62M.

  • $50M$100M

    ImmunoGen, Inc.'s revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.